Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. W. Hay
Interactions of Abiraterone, Eplerenone, and Prednisolone With Wild-Type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining With MDV3100
Cancer Research
Cancer Research
Oncology
Related publications
Porphyrin Interactions With Wild-Type and Mutant Mouse Ferrochelatase†
Biochemistry
Biochemistry
Prognostic Factors for Patients Treated With Abiraterone
Future Science OA
Medicine
Biotechnology
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer
Einstein (São Paulo, Brazil)
Medicine
Pih13 - Abiraterone: A Single-Centre Experience
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Structures of Cytochrome P450 17A1 With Prostate Cancer Drugs Abiraterone and TOK-001
Nature
Multidisciplinary
Activity of Abiraterone in Rechallenging Two AR-expressing Salivary Gland Adenocarcinomas, Resistant to Androgen-Deprivation Therapy
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Pd28-04 Detection of Androgen Receptor Variant 7 (Ar-V7) in Whole Blood Rna of Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Treated With Abiraterone Acetate (Abi)
Journal of Urology
Urology
